GigCapital5 (GIA) Appoints Sharmila Makhija to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Dr. Sharmila Makhija Joins GigCapital5 Board of Directors
January 5, 2022 4:15 PM ESTPALO ALTO, Calif.--(BUSINESS WIRE)-- GigCapital5, Inc. (NYSE: GIA, GIA.U, GIA.WS) (the Company or GigCapital5) today announced that Dr. Sharmila Makhija, MD, MBA, an international expert on gynecologic cancer, has joined the Companys Board of Directors.
In addition, Dr. Makhija will serve as Healthcare Advisor to GigCapital5s affiliate and serial SPAC issuer GigCapital Global (GigCapital). In her role as Healthcare Advisor to GigCapital, Dr. Makhija provides her medical and business expertise across its Private-to-Public Equity (PPE) initiatives, which includes six public SPACs, four of which have closed transactions Kaleyra (NYSE: KLR),... More
